Not long ago, I reported here on the possible benefits of Metformin for people with type 1 diabetes. It is of course an oral medication traditionally aimed at type 2 diabetics who are not on insulin. Today, we revisit that issue with a real live test case — my friend and colleague Allison Blass, who’s recently added Metformin to her own regime:
A Guest Post by Allison Blass
Over the past few years, since graduating…
Novo Nordisk is well-known in the diabetes community for its insulins, Novolog and Levemir, used to treat mainly type 1 diabetes. But in the last year, Novo launched a new kind of injectable, a “first line of defense for people with type 2 diabetes” called Victoza (generic: liraglutide). It’s a glucagon-like peptide-1 (GLP-1) drug designed to stimulate insulin secretion when hyperglycemia (high blood sugar) is present.
Victoza is still the new kid on the block…
Read more »
Time-check: I can’t believe it’s mid (to late) February already! Where do the days go and weeks go? So, how many of you have left New Year’s Resolutions in the dust yet? Yeah, life happens. For those of you whose Resolutions had something to do with starting a new exercise routine, I thought you might enjoy this little ‘guide,’ originally published in Fall 2005:
How to Start Jogging, in 3 Easy Steps
Did you read…
You’ve heard it before: someone with type 2 diabetes goes on insulin. That’s no surprise. But how often have you heard the reverse — someone with type 1 going on Metformin?
Since the launch of Symlin in 2005, it’s not uncommon for people to treat their type 1 diabetes with a supplemental injectable medication. But hang around long enough, and you too might get to know someone with type 1 who takes insulin and oral meds,…
Al Mann, CEO of MannKind Corp., is something of a legend in his own time. He not only founded MiniMed, acquired by Medtronic, but also four other successful medical companies. He’s a billionaire, with his own Biomedical Engineering Institute at the University of Southern California (USC), so we can assume that he’s not just championing the new inhalable insulin product Technosphere (brand name Afresa) as some kind of pipe dream or get-rich-quick scheme.
The guy…